DaikyoNishikawa Corporation (PK) (DKYNF) ニュース

This makes it clear. Very interesting. The cork allows for a tiny amount of oxygen over time, from the cork itself (not through it), which is good for some reds, only. And always bad for whites. Yes, some air does enter the wine from the cork, but not through the cork.
https://www.decanterc

I was just going to post this. Thanks for bring it to the board! 👍️

It will all be over for NSAV this week or next. Bankruptcy or expert market coming. Lawyer gone who they haven't paid. NSAV is done and broke. Judge is going to come down hard on Tilton and NSAV. Clear as day. The judge hates Tilton. He will represent NSAV in the next hearing? 🤣ǹ

We have a new crow in town

It’s a clear and rather surprising miss by the market. Even a small chance of liability years away should have elicited *some* reaction. But the market has been weird when it comes to this stuff it seems. Zantac for example didn’t affect companies much until the litigation moved further along and t

Reddit comments on CV*NA. Telling you all, this is the next CV*NA but it will be a lot faster and furious.

https://www.reddit.com/r/wallstreetbets/comments/1e456ww/cvna_its_a_short_dont_act_like_i_never_told_ya/?rdt=59586

Probably for good reason. RS announcements are bad news.

L

Let the takeover wars begin.

Where do you think those 20 people work for?

Illinois, a default judgment can be vacated within 30 days by filing a written motion with the court. The motion must be sent to the other party in the case, and the filer must appear in court for a hearing. The trial court has the discretion to grant or deny the motion.

Approved - Or

Those sites are not reliable, they are all over the place. If you believe that “gentleman” that there were 20 people working, then it cant’t be Mvnt since those costs are not showing anywhere in mvnt financials. My only guess is they are under Velocity, not sure where else can they be. Unless, L

SEC DELINQUENT NOTICE ON ASII

For sure!

News that is IMMINENT

A lot of news to be expected prior to the end of the year 2024

Alzheimer’s disease: Data from the blarcamesine Phase 2b/3 ANAVEX®2-73-AD-004 trial to be published in an upcoming peer-reviewed journal

Alzheimer’s disease: Full reg

I've been trying to buy pizza and subs for the past 10 years.

“ I agree, crescent, that the announcement this evening is quite unusual.”

Its quite a bit different than last time they released data by releasing their past trial data twice, one week apart. The first time the stock wd t absolutely nowhere. The second time they released it the stock

Paid full price for Brand Vascepa last time(after 7/01/2024). 

Typo: There is a patent infringement suit in Delaware, not yet an antitrust suit there.

BIEL (Bioelectronics): #5 BREAKOUT BOARD + #5 MOST READ (last hour)!

Hey Trump Voters .........

https://i.postimg.cc/sxY6Q0K0/IMG-4787.jpg